Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q3 EPS of ($0.33), $0.02 worse than the analyst estimate of ($0.31).

Outlook:
This article: 107 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE